Ellevest Inc’s Zevra Therapeutics ZVRA Stock Holding History

Ellevest Inc’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15	Closed	–	–	1728
2022 Q1	$0	Buy	+15	New	+$95	﹤0.01%	1660
2021 Q4	–	Sell	-9	Closed	–	–	1678
2021 Q3	$0	Buy	+9	New	+$91	﹤0.01%	1606

Other funds holding ZVRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

RPCONE

Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Ellevest Inc's ZVRA Position: Q2 2022 in Review

Ellevest Inc sold out of Zevra Therapeutics (ZVRA) in Q2 2022, closing a stake of 15 shares.

Ellevest Inc first reported a position in ZVRA in Q3 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 72 funds tracked by Wall St. Rank hold ZVRA as of Q2 2022.

Ellevest Inc reported no remaining Zevra Therapeutics position as of Q2 2022 after selling out during the quarter.
Ellevest Inc sold 15 Zevra Therapeutics shares in Q2 2022.
Ellevest Inc first reported a position in Zevra Therapeutics in Q3 2021 and held it in 2 quarters.
Ellevest Inc's Zevra Therapeutics position peaked at $0 in Q1 2022.
72 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2022.

Based on Ellevest Inc's 13F filing for Q2 2022, filed 18 Jul 2022.